Mitcon Consultancy & Engineering Services Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:13 am

Competitors of Mitcon Consultancy & Engineering Services Ltd

All Competitor Stocks of Mitcon Consultancy & Engineering Services Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:55 am

Below is a detailed analysis of the quarterly data for Mitcon Consultancy & Engineering Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 24.43 Cr.. The value appears to be declining and may need further review. It has decreased from 38.13 Cr. (Mar 2025) to 24.43 Cr., marking a decrease of 13.70 Cr..
• For Expenses, as of Jun 2025, the value is 18.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 30.80 Cr. (Mar 2025) to 18.02 Cr., marking a decrease of 12.78 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.41 Cr.. The value appears to be declining and may need further review. It has decreased from 7.33 Cr. (Mar 2025) to 6.41 Cr., marking a decrease of 0.92 Cr..
• For OPM %, as of Jun 2025, the value is 26.24%. The value appears strong and on an upward trend. It has increased from 19.22% (Mar 2025) to 26.24%, marking an increase of 7.02%.
• For Other Income, as of Jun 2025, the value is 0.41 Cr.. The value appears to be declining and may need further review. It has decreased from 0.59 Cr. (Mar 2025) to 0.41 Cr., marking a decrease of 0.18 Cr..
• For Interest, as of Jun 2025, the value is 2.82 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.86 Cr. (Mar 2025) to 2.82 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 2.34 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.37 Cr. (Mar 2025) to 2.34 Cr., marking a decrease of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.66 Cr.. The value appears to be declining and may need further review. It has decreased from 2.69 Cr. (Mar 2025) to 1.66 Cr., marking a decrease of 1.03 Cr..
• For Tax %, as of Jun 2025, the value is 27.71%. The value appears to be improving (decreasing) as expected. It has decreased from 36.43% (Mar 2025) to 27.71%, marking a decrease of 8.72%.
• For Net Profit, as of Jun 2025, the value is 1.20 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Mar 2025) to 1.20 Cr., marking a decrease of 0.50 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.81. The value appears to be declining and may need further review. It has decreased from 1.26 (Mar 2025) to 0.81, marking a decrease of 0.45.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:51 am

Balance Sheet

Last Updated: October 10, 2025, 2:33 pm

Below is a detailed analysis of the balance sheet data for Mitcon Consultancy & Engineering Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 102.00 Cr. (Mar 2024) to 112.00 Cr., marking an increase of 10.00 Cr..
• For Borrowings, as of Mar 2025, the value is 113.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 144.00 Cr. (Mar 2024) to 113.00 Cr., marking a decrease of 31.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 47.00 Cr.. The value appears to be improving (decreasing). It has decreased from 52.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 286.00 Cr.. The value appears to be improving (decreasing). It has decreased from 312.00 Cr. (Mar 2024) to 286.00 Cr., marking a decrease of 26.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 164.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 164.00 Cr., marking an increase of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 36.00 Cr..
• For Other Assets, as of Mar 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2024) to 114.00 Cr., marking an increase of 8.00 Cr..
• For Total Assets, as of Mar 2025, the value is 286.00 Cr.. The value appears to be declining and may need further review. It has decreased from 312.00 Cr. (Mar 2024) to 286.00 Cr., marking a decrease of 26.00 Cr..

However, the Borrowings (113.00 Cr.) are higher than the Reserves (112.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Mitcon Consultancy & Engineering Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.20 (Mar 24) to 4.63, marking an increase of 0.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.00. This value is below the healthy minimum of 5. It has decreased from 4.18 (Mar 24) to 4.00, marking a decrease of 0.18.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.56. This value is within the healthy range. It has increased from 10.52 (Mar 24) to 11.56, marking an increase of 1.04.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.43. It has increased from 86.07 (Mar 24) to 87.43, marking an increase of 1.36.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 87.43. It has increased from 86.07 (Mar 24) to 87.43, marking an increase of 1.36.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 77.74. It has decreased from 96.36 (Mar 24) to 77.74, marking a decrease of 18.62.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 21.92. This value is within the healthy range. It has decreased from 24.21 (Mar 24) to 21.92, marking a decrease of 2.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.64. This value is within the healthy range. It has decreased from 18.46 (Mar 24) to 15.64, marking a decrease of 2.82.
• For PBT / Share (Rs.), as of Mar 25, the value is 6.27. This value is within the healthy range. It has decreased from 7.91 (Mar 24) to 6.27, marking a decrease of 1.64.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 4.78 (Mar 24) to 5.28, marking an increase of 0.50.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.83. This value is within the healthy range. It has decreased from 3.97 (Mar 24) to 3.83, marking a decrease of 0.14.
• For PBDIT Margin (%), as of Mar 25, the value is 28.19. This value is within the healthy range. It has increased from 25.12 (Mar 24) to 28.19, marking an increase of 3.07.
• For PBIT Margin (%), as of Mar 25, the value is 20.11. This value exceeds the healthy maximum of 20. It has increased from 19.15 (Mar 24) to 20.11, marking an increase of 0.96.
• For PBT Margin (%), as of Mar 25, the value is 8.07. This value is below the healthy minimum of 10. It has decreased from 8.21 (Mar 24) to 8.07, marking a decrease of 0.14.
• For Net Profit Margin (%), as of Mar 25, the value is 6.79. This value is within the healthy range. It has increased from 4.95 (Mar 24) to 6.79, marking an increase of 1.84.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 8. It has increased from 4.12 (Mar 24) to 4.92, marking an increase of 0.80.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 15. It has decreased from 4.61 (Mar 24) to 4.38, marking a decrease of 0.23.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.96. This value is below the healthy minimum of 10. It has increased from 9.69 (Mar 24) to 9.96, marking an increase of 0.27.
• For Return On Assets (%), as of Mar 25, the value is 1.94. This value is below the healthy minimum of 5. It has increased from 1.71 (Mar 24) to 1.94, marking an increase of 0.23.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.59. This value is within the healthy range. It has decreased from 0.92 (Mar 24) to 0.59, marking a decrease of 0.33.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.83. This value is within the healthy range. It has decreased from 1.13 (Mar 24) to 0.83, marking a decrease of 0.30.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.37. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.37, marking a decrease of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.26, marking a decrease of 0.14.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.34. This value is below the healthy minimum of 3. It has increased from 2.29 (Mar 24) to 2.34, marking an increase of 0.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 3. It has increased from 1.45 (Mar 24) to 1.56, marking an increase of 0.11.
• For Enterprise Value (Cr.), as of Mar 25, the value is 236.26. It has decreased from 288.88 (Mar 24) to 236.26, marking a decrease of 52.62.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.90, marking a decrease of 0.33.
• For EV / EBITDA (X), as of Mar 25, the value is 6.73. This value is within the healthy range. It has decreased from 8.89 (Mar 24) to 6.73, marking a decrease of 2.16.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.17 (Mar 24) to 0.90, marking a decrease of 0.27.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.80. This value is below the healthy minimum of 1. It has decreased from 1.31 (Mar 24) to 0.80, marking a decrease of 0.51.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.17 (Mar 24) to 0.90, marking a decrease of 0.27.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness